- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07429292
SPARK Study - Sympathetic Periarterial Radial Block in Healthy Volunteers (SPARK)
March 27, 2026 updated by: Duke University
SPARK Study - Sympathetic PeriArterial Radial blocK Study
The SPARK Study evaluates changes in peripheral sympathetic vasomotor activity following a targeted, ultrasound-guided periarterial sympathetic block of the distal radial artery in healthy volunteers.
Autonomic reactivity will be assessed before and after the block using digit-specific pulse-amplitude index and infrared thermography during standardized cold pressor testing.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age 18-50 years
- ASA physical status I-II
- Able to understand and provide informed consent
- Able to comply with study procedures and follow-up
- Two hands with 5 intact digits and no significant upper extremity injury
Exclusion Criteria:
- Allergy to lidocaine or similar anesthetics
- Allergy to adhesives or ultrasound gel
- Neuromuscular, autonomic, or major vascular disorders affecting upper extremities
- Peripheral neuropathy
- Raynaud's phenomenon or digital ischemia
- Coagulopathy or anticoagulation
- Active skin infection near block site
- Pregnancy
- BMI > 35 kg/m²
- Inability to tolerate cold exposure
- Any condition interfering with study conduct
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Left Wrist Block
Ultrasound-guided periarterial block with 2% lidocaine at left wrist.
|
Small-volume injection (5 mL) of 2% lidocaine around radial artery under ultrasound guidance.
|
|
Experimental: Right Wrist Block
Ultrasound-guided periarterial block with 2% lidocaine at right wrist.
|
Small-volume injection (5 mL) of 2% lidocaine around radial artery under ultrasound guidance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pulse amplitude index (PAI)
Time Frame: PAI will be measured at: 1) Baseline; 2) after the first cold pressor test at 0, 5, 10, and 15 minutes; 3) after the sympathetic block at 5 and 10 minutes; 4) after the second cold pressor test at 0, 5, 10, and 15 minutes.
|
Pulse Amplitude Index (PAI) is a noninvasive measure of digital perfusion derived from photoplethysmography (PPG) signals recorded from the fingers.
PAI reflects changes in pulse waveform amplitude and serves as an indirect marker of peripheral blood flow and sympathetic vasomotor tone.
In this study, PAI will be continuously recorded using digital sensors placed on the index and fifth fingers of the hand undergoing periarterial radial block, as well as the contralateral index finger.
Measurements will be obtained at baseline, following cold pressor testing, after the periarterial radial block, and following repeat cold pressor testing.
Changes in PAI across time points will be used to assess alterations in peripheral perfusion associated with sympathetic modulation.
|
PAI will be measured at: 1) Baseline; 2) after the first cold pressor test at 0, 5, 10, and 15 minutes; 3) after the sympathetic block at 5 and 10 minutes; 4) after the second cold pressor test at 0, 5, 10, and 15 minutes.
|
|
Hand temperature
Time Frame: Thermal images will be obtained at: 1) Baseline; 2) after the first cold pressor test at 0, 5, 10, and 15 minutes; 3) after the sympathetic block at 5 and 10 minutes; 4) after the second cold pressor test at 0, 5, 10, and 15 minutes.
|
Hand temperature is a noninvasive measure of peripheral skin temperature used as an indicator of changes in local blood flow and sympathetic vasomotor activity.
In this study, hand temperature will be assessed using infrared thermographic imaging of both hands.
Thermal images will be acquired under standardized environmental conditions at baseline, following cold pressor testing, after the periarterial radial block, and following repeat cold pressor testing.
Temperature values will be derived from predefined regions of interest on the hands based on arterial territories, and compared across time points to evaluate changes in peripheral perfusion associated with sympathetic modulation.
|
Thermal images will be obtained at: 1) Baseline; 2) after the first cold pressor test at 0, 5, 10, and 15 minutes; 3) after the sympathetic block at 5 and 10 minutes; 4) after the second cold pressor test at 0, 5, 10, and 15 minutes.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Temporal Changes in Cold Pressor Test-Induced Vasomotor Responses Pre- and Post-Block
Time Frame: Data will be obtained at: 1) Baseline; 2) after the first cold pressor test at 0, 5, 10, and 15 minutes; 3) after the sympathetic block at 5 and 10 minutes; 4) after the second cold pressor test at 0, 5, 10, and 15 minutes.
|
Temporal changes in cold pressor test (CPT)-induced vasomotor responses pre- and post-block refer to time-dependent alterations in peripheral vascular tone before and after periarterial radial block-induced sympathetic modulation.
In this study, CPT-induced vasomotor responses will be assessed by evaluating changes in pulse amplitude index (PAI) and hand skin temperature across predefined time points.
Measurements will be obtained immediately following CPT, and at serial intervals.
CPT will be performed before and after the periarterial radial block.
Comparisons of these temporal response patterns before and after the block will be used to characterize the effects of sympathetic modulation on peripheral vasoconstriction and vasodilation.
|
Data will be obtained at: 1) Baseline; 2) after the first cold pressor test at 0, 5, 10, and 15 minutes; 3) after the sympathetic block at 5 and 10 minutes; 4) after the second cold pressor test at 0, 5, 10, and 15 minutes.
|
|
Change in Vasomotor Measures in the Fifth Finger
Time Frame: PAI and thermal images will be measured at: 1) Baseline; 2) after the first cold pressor test at 0, 5, 10, and 15 minutes; 3) after the sympathetic block at 5 and 10 minutes; 4) after the second cold pressor test at 0, 5, 10, and 15 minutes.
|
Change in vasomotor measures in the fifth finger refers to alterations in peripheral perfusion and skin temperature measured in the fifth digit ipsilateral to the periarterial radial block, an area predominantly innervated by the ulnar nerve.
In this study, the fifth finger will serve as an internal control for comparison with the radial-innervated index finger.
Changes will be assessed using pulse amplitude index (PAI) and infrared thermographic imaging.
Measurements will be obtained at baseline, following cold pressor testing, after periarterial radial block, and following repeat cold pressor testing.
Responses in the ulnar-innervated fifth finger will be used to evaluate regional vasomotor changes and to track potential extension of radial sympathetic modulation to adjacent, non-radial territories.
|
PAI and thermal images will be measured at: 1) Baseline; 2) after the first cold pressor test at 0, 5, 10, and 15 minutes; 3) after the sympathetic block at 5 and 10 minutes; 4) after the second cold pressor test at 0, 5, 10, and 15 minutes.
|
|
Change in Vasomotor Measures in the Contralateral Index Finger
Time Frame: PAI and thermal images will be measured at: 1) Baseline; 2) after the first cold pressor test at 0, 5, 10, and 15 minutes; 3) after the sympathetic block at 5 and 10 minutes; 4) after the second cold pressor test at 0, 5, 10, and 15 minutes.
|
Change in vasomotor measures in the contralateral index finger refers to alterations in peripheral perfusion and skin temperature measured in the index finger of the hand opposite to the periarterial radial block.
This contralateral finger serves as an internal control to account for systemic sympathetic responses to cold pressor testing that are independent of the local effects of the block and to compare sympathetic reactivity between hands.
Vasomotor measures will be assessed using pulse amplitude index (PAI) derived from photoplethysmography and infrared thermographic imaging.
Measurements will be obtained at baseline, following cold pressor testing, after periarterial radial block, and following repeat cold pressor testing.
Changes across time points will be used to distinguish local from systemic vasomotor effects.
|
PAI and thermal images will be measured at: 1) Baseline; 2) after the first cold pressor test at 0, 5, 10, and 15 minutes; 3) after the sympathetic block at 5 and 10 minutes; 4) after the second cold pressor test at 0, 5, 10, and 15 minutes.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Macleod, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
April 1, 2027
Study Registration Dates
First Submitted
February 18, 2026
First Submitted That Met QC Criteria
February 18, 2026
First Posted (Actual)
February 24, 2026
Study Record Updates
Last Update Posted (Actual)
April 1, 2026
Last Update Submitted That Met QC Criteria
March 27, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- Pro00119632
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
Clinical Trials on Lidocaine 2%
-
Cairo UniversityCompletedNeuropathic Pain Induced by MastectomyEgypt
-
Ataturk UniversityRecruitingPain, Postoperative | Nerve Block | Lower Extremity | Pain, NerveTurkey (Türkiye)
-
Jinnah Postgraduate Medical CentreNot yet recruitingPost Operative Sore Throat at 6hrs and 24hrs After Endotracheal Intubation
-
Cairo UniversityRecruitingMyofascial Pain Dysfunction SyndromeEgypt
-
Institute for Oncology and Radiology of SerbiaRecruitingAnxiety | Acute Pain | Central Venous CatheterSerbia
-
Cairo UniversityNot yet recruitingMyofacial Pain Syndromes | Trigger Point Pain, Myofascial | Myofacial Pain | Myofacial Pain Syndrome | Myofascial Pain Dysfunction SyndromeEgypt
-
Monash UniversityRoyal Perth HospitalRecruitingBreast Cancer | Mastectomy | Breast Cancer Female | Breast Conserving SurgeryAustralia, United Kingdom, Hong Kong, New Zealand
-
Stanford UniversityWithdrawn
-
Northwestern UniversityFirst Lviv Medical UnionNot yet recruiting
-
Ankara City Hospital BilkentCompletedSedation | ERCP | Duodenal SpasmTurkey (Türkiye)